Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	21.44	163.29	134.46
Graham Fair Price	-72.87	0.44	1.63
PEG	2869.74	9.49	-0.32
Price/Book	0.24	3.96	3.95
Price/Cash Flow	90.25	178.40	93.77
Prices/Earnings	1354.26	-1014.91	69.79
Price/Sales	0.91	31.07	30.79
Price/FCF	90.25	178.40	93.77
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-2.20	0.74	0.76
Operating Margin	-59.49	0.03	0.08
ROA	-93.04	< 0.005	< 0.005
ROE	0.01	< 0.005	-93.11
ROIC	< 0.005	< 0.005	-93.74
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	22.25
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.17	-0.60	254.75
EPS QOQ	2.18	-1.07	-51.03
FCF QOQ	0.62	-0.47	-23.43
Revenue QOQ	0.03	< 0.005	-82.30
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	63.65	59.72	-6.18
Days Sales Outstanding (DSO)	41.01	40.40	-1.48
Inventory Turnover	1.41	1.51	6.59
Debt/Capitalization	0.32	0.32	-0.21
Quick Ratio	1.96	2.16	10.10
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	2.88	2.98	3.35
Cash	0.32	0.32	0.96
Capex	-0.02	-0.03	-36.57
Free Cash Flow	0.12	0.07	-45.54
Revenue	0.37	0.38	2.66
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.29	2.53	10.37
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	11.17	13.57	21.51
Naive Interpretation	Member

06 - Financial Health · Bad

Rating